欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是 分享到:

中国临床药理学与治疗学 ›› 2020, Vol. 25 ›› Issue (9): 1038-1042.doi: 10.12092/j.issn.1009-2501.2020.09.012

• 医院药学之窗 • 上一篇    下一篇

临床药师在癌痛规范化病房中的作用分析

周海辉,张海霞,葛卫红   

  1. 南京大学医学院附属鼓楼医院药学部临床药学科,南京 210008,江苏
  • 收稿日期:2020-06-15 修回日期:2020-08-11 出版日期:2020-09-26 发布日期:2020-09-30
  • 通讯作者: 葛卫红,女,硕士,主任药师,研究方向:临床药学。 Tel: 025-83105670 E-mail: gewhgy@126.com
  • 作者简介:周海辉,男,博士,副主任药师,研究方向:药理学研究、临床药学。 Tel: 025-83105670 E-mail: zhhhnj@126.com
  • 基金资助:
    国家自然科学基金资助项目(81601153)

Analysis of the role of clinical pharmacist in the establishment of standardized cancer pain management ward

ZHOU Haihui, ZHANG Haixia, GE Weihong   

  1. Division of Clinical Pharmacy, Department of Pharmacy, Drum Tower Hospital Affiliated to Medical School of Nanjing University, Nanjing 210008, Jiangsu, China
  • Received:2020-06-15 Revised:2020-08-11 Online:2020-09-26 Published:2020-09-30

摘要: 目的:探讨肿瘤专业临床药师在我院癌痛规范化病房创建中的作用效果。方法:回顾性收集整理肿瘤科2018年1-6月和2018年7-12月癌痛患者的住院信息分别作为对照组和干预组,共纳入患者114例进行研究,对照组58例,干预组56例。一般信息包括性别、年龄、BMI、肿瘤类型、Karnofsky功能状态(KPS)评分、疼痛数字评分法(NRS)评分等,基值无统计学差异。对比临床药师参与前后患者的镇痛效果。结果: 患者的疼痛评分干预组较对照组显著降低(P<0.05)、爆发痛次数干预组较对照组显著降低(P<0.05)、KPS评分干预组较对照组显著升高(P<0.05)、不良反应总发生率干预组较对照组显著降低(P<0.05)。结论:临床药师参与癌痛规范化病房的诊疗有助于提高患者的癌痛规范化治疗水平,提高肿瘤患者的生存质量。

关键词: 临床药师, 癌痛病房, 肿瘤

Abstract: AIM: To explore the role of clinical pharmacists in the establishment of standardized cancer pain management ward in our hospital. METHODS: Information of hospitalized patients with cancer pain admitted to the oncology department from January to June 2018 and from July to December 2018 was retrospectively collected and was allocated as the control group and the intervention group, respectively. A total of 114 patients were included in the study, including 58 in the control group and 56 in the intervention group. General information included gender, age, body mass index, tumor type, KPS score, NRS score, etc was collected. There was no statistical difference of the baseline value. The analgesic effect before and after clinical pharmacists' participation was compared. RESULTS: The pain score in the intervention group was significantly lower than that in the control group (P<0.05), the number of pain occurence in the intervention group was significantly lower than that in the control group (P<0.05), and the total incidence of adverse reactions in the intervention group was significantly lower than that in the control group (P<0.05), and KPS score in the intervention group was significantly higher than that in the control group (P<0.05). CONCLUSION: Participant of clinical pharmacists in the diagnosis and treatment of standardized cancer pain ward elevates the standardized treatment level of cancer pain and improves the life qualityof cancer patients.

Key words: clinical pharmacist, cancer pain ward, tumor

中图分类号: